Delphinapterus leucas (beluga whale): 111179463
Help
Entry
111179463 CDS
T05885
Gene name
PLCG2
Definition
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2
KO
K05859
phosphatidylinositol phospholipase C, gamma-2 [EC:
3.1.4.11
]
Organism
dle
Delphinapterus leucas (beluga whale)
Pathway
dle00562
Inositol phosphate metabolism
dle01100
Metabolic pathways
dle01521
EGFR tyrosine kinase inhibitor resistance
dle04012
ErbB signaling pathway
dle04014
Ras signaling pathway
dle04020
Calcium signaling pathway
dle04062
Chemokine signaling pathway
dle04064
NF-kappa B signaling pathway
dle04066
HIF-1 signaling pathway
dle04070
Phosphatidylinositol signaling system
dle04072
Phospholipase D signaling pathway
dle04360
Axon guidance
dle04370
VEGF signaling pathway
dle04380
Osteoclast differentiation
dle04611
Platelet activation
dle04613
Neutrophil extracellular trap formation
dle04625
C-type lectin receptor signaling pathway
dle04650
Natural killer cell mediated cytotoxicity
dle04662
B cell receptor signaling pathway
dle04664
Fc epsilon RI signaling pathway
dle04666
Fc gamma R-mediated phagocytosis
dle04670
Leukocyte transendothelial migration
dle04722
Neurotrophin signaling pathway
dle04750
Inflammatory mediator regulation of TRP channels
dle04919
Thyroid hormone signaling pathway
dle04933
AGE-RAGE signaling pathway in diabetic complications
dle04935
Growth hormone synthesis, secretion and action
dle05167
Kaposi sarcoma-associated herpesvirus infection
dle05169
Epstein-Barr virus infection
dle05170
Human immunodeficiency virus 1 infection
dle05171
Coronavirus disease - COVID-19
dle05200
Pathways in cancer
dle05205
Proteoglycans in cancer
dle05206
MicroRNAs in cancer
dle05214
Glioma
dle05223
Non-small cell lung cancer
dle05225
Hepatocellular carcinoma
Module
dle_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
dle00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
111179463 (PLCG2)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
111179463 (PLCG2)
04014 Ras signaling pathway
111179463 (PLCG2)
04370 VEGF signaling pathway
111179463 (PLCG2)
04064 NF-kappa B signaling pathway
111179463 (PLCG2)
04066 HIF-1 signaling pathway
111179463 (PLCG2)
04020 Calcium signaling pathway
111179463 (PLCG2)
04070 Phosphatidylinositol signaling system
111179463 (PLCG2)
04072 Phospholipase D signaling pathway
111179463 (PLCG2)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
111179463 (PLCG2)
04613 Neutrophil extracellular trap formation
111179463 (PLCG2)
04625 C-type lectin receptor signaling pathway
111179463 (PLCG2)
04650 Natural killer cell mediated cytotoxicity
111179463 (PLCG2)
04662 B cell receptor signaling pathway
111179463 (PLCG2)
04664 Fc epsilon RI signaling pathway
111179463 (PLCG2)
04666 Fc gamma R-mediated phagocytosis
111179463 (PLCG2)
04670 Leukocyte transendothelial migration
111179463 (PLCG2)
04062 Chemokine signaling pathway
111179463 (PLCG2)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
111179463 (PLCG2)
04919 Thyroid hormone signaling pathway
111179463 (PLCG2)
09156 Nervous system
04722 Neurotrophin signaling pathway
111179463 (PLCG2)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
111179463 (PLCG2)
09158 Development and regeneration
04360 Axon guidance
111179463 (PLCG2)
04380 Osteoclast differentiation
111179463 (PLCG2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
111179463 (PLCG2)
05206 MicroRNAs in cancer
111179463 (PLCG2)
05205 Proteoglycans in cancer
111179463 (PLCG2)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
111179463 (PLCG2)
05214 Glioma
111179463 (PLCG2)
05223 Non-small cell lung cancer
111179463 (PLCG2)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
111179463 (PLCG2)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
111179463 (PLCG2)
05171 Coronavirus disease - COVID-19
111179463 (PLCG2)
05167 Kaposi sarcoma-associated herpesvirus infection
111179463 (PLCG2)
05169 Epstein-Barr virus infection
111179463 (PLCG2)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
111179463 (PLCG2)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
dle04131
]
111179463 (PLCG2)
Enzymes [BR:
dle01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
111179463 (PLCG2)
Membrane trafficking [BR:
dle04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
111179463 (PLCG2)
Endocytosis
Macropinocytosis
Phospholipase C
111179463 (PLCG2)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
C2
SH3_1
SH3_9
PH
SH3_2
PH_12
PH_14
EF-hand_like
Motif
Other DBs
NCBI-GeneID:
111179463
NCBI-ProteinID:
XP_022438794
UniProt:
A0A2Y9NXP3
LinkDB
All DBs
Position
Unknown
AA seq
1265 aa
AA seq
DB search
MSTTVNVDALPEYEKSQIKRALELGTVMTVFSFRKSTPERRTVQVIMETQQVAWSKTADK
IEGFLDIMEIKEIRPGKNSKDFERAKAVRQKEECCFTILYGTQFVLSTLSLAADSKEDAT
KWLSGLKILHQEVMNASTPTIIESWLRKQIYSVDQTRRNSISLRELKTILPLVNFKVSSA
KFLKDKFVEIGAHKDELSFEQFHLFYKKLMFEQQKLILDEFKKDSSVFILGNTDRPDASA
VHLHDFQRFLLHEQQELWAQDLNKVRERMTKFIDDTMRETAEPFLFVDEFLTYLFSRENS
IWDEKYDVVDVQDMNNPLSHYWISSSHNTYLTGDQLRSESSPEAYIRCLRMGCRCIELDC
WDGPDGKPIIYHGWTRTTKIKFDDVVQAIKDHAFVTSSFPVILSIEEHCCLQQQRHMARV
FKEAFGDLLLTKPTEASADQLPSPSQLREKIIIKHKKLGPRGDVDVNVEDKKDEHRQQGE
LYMWDSIDQRWTRHYCAIADAKLSFSDDIEQTTEGEQPPDIAPTELHFGEKWFHKKVEKR
TSAEKLLQEYCAETGGKDGTFLVRESETYPNDYTLSFWRSGRVQHCRIRSTMEGGTLKYY
LTDNLMFTSIYALIQHYSETHLRCAEFELRLTDPVPNPSPHESKPWYYDGLSRGEAEDML
MRVPRDGAFLIRKREGSDSYAITFRARGKVKHCRINRDGRHFVLGTSAYFESLVELVSYY
EKHALYRKMKLRYPVTPELLERYNMERDINSLYDVSRMYVDPSEISPSMPQRTVKALYDY
KAKRNDELSFCRGALIHNVSKEPGGWWKGDYGTRIQQYFPSNYVEDISTADGEDLEKQII
EDNPLGSLCRGILDLNTYNVVKAPQGKNQKPFVFILEPKKQGDPPVEFATDKVEELFEWF
QSIREITWKIDTKENNMKYWEKNQSIAIELSDLVVYCKPTSKTKDNLENPDFREIRSFVE
TKADSIVRQKPNDLLKYNQKGLTRVYPKGQRVDSSNYDPFRLWLCGSQMVALNFQTPDKY
LQMNHALFSLNGRTGYVLQPESMRAEKYDPMPPESQRKILMTLTVKVLGARHLPKPGRSI
ACPFVEVEICGAEYDNNKFKTTVVNDNGLSPVWAPTQEKVTFEIYDPNLAFLRFVVYEED
MFSDPNFLAHATFPIKGIKSGFRSVPLKNGYSEDMELASLLVFCEMRPVLESEEELYSSC
RQLRRRQEELNNQLFLYDTHQNLRSANRDALVREFNVNENQLQLYQEKCNRRLREKRVSN
SKFYS
NT seq
3798 nt
NT seq
+upstream
nt +downstream
nt
atgagcaccacggtcaacgtggacgcccttccggagtacgagaagagtcagatcaagagg
gccctggagctgggcacggtgatgacggtgttcagcttccgcaagtccaccccggagcgg
aggactgtccaggtgatcatggagacccagcaggtggcctggagcaagacggccgataag
atcgagggcttcctggatatcatggaaataaaggaaatccgcccagggaagaactccaag
gattttgagcgtgcgaaagcagtccgtcagaaggaagagtgctgcttcaccatcttgtat
ggcacccagttcgtcctcagcacgctcagcttagcagccgactctaaagaagatgcaact
aagtggctctctggcttgaagatcttgcaccaggaagtgatgaacgcatccacccccacc
atcattgagagttggttgcgaaagcagatttattctgtggatcagaccagaagaaacagc
atcagcctccgagagttgaagaccatcttgcccctggtcaacttcaaagtgagcagcgcc
aagttcctcaaagataagttcgtggaaataggagcacacaaagatgaactcagctttgaa
cagttccatctcttctataaaaaacttatgtttgaacagcagaaattgattcttgacgaa
ttcaaaaaggattcctccgtgttcatcttgggcaacaccgaccggccggatgcctccgct
gttcacctgcatgacttccagcggtttctcttacatgaacagcaggagctttgggcccag
gatctgaacaaagtccgtgagcggatgacaaagttcattgatgacacgatgagagaaact
gccgagcccttcctgtttgtggatgagttcctcacgtacctgttttcccgggagaacagc
atttgggatgagaagtatgacgtggtggatgtgcaggacatgaacaaccccttgtctcat
tactggatctcctcatcacataacacgtacctcacgggtgaccagcttcggagcgagtcg
tccccggaggcctatatccgctgtctgcggatgggctgccgctgcattgagctggactgc
tgggacgggcccgacgggaagcccatcatctaccacggctggacgcggaccaccaagatc
aagtttgatgacgtcgtgcaggccatcaaggaccatgcctttgtcacctcgagcttcccc
gtgatcctgtccatcgaggagcactgctgcctgcagcagcagcgccacatggccagggtg
ttcaaggaggcgttcggcgacctgctgctgaccaagcccacggaggccagtgccgaccag
ctgccgtcgcccagccagctgcgggagaagatcatcatcaagcataagaagctgggcccc
cgaggcgacgtggatgtcaacgtggaggacaagaaagatgaacacaggcagcagggtgaa
ctgtacatgtgggattccatcgaccagcgatggactcggcactactgcgccattgctgac
gccaagctgtccttcagcgacgacattgaacagactacggaaggtgaacagcccccggat
atagcccccacggagctgcattttggggagaagtggttccacaagaaggtggagaagagg
acaagcgccgagaagctgctgcaggaatactgcgccgagacggggggcaaggatgggacc
ttcttggtgcgggagagcgagacgtaccccaatgactacaccctgtccttctggcggtcg
ggccgcgtccagcactgccggatccgctccaccatggagggcgggaccctgaagtattac
ctgactgacaacctcatgttcaccagcatctatgccctcatccagcactacagcgagacg
cacctgcgctgtgccgagttcgagctccggctcaccgacccagttcccaaccccagcccg
cacgagtcgaagccgtggtactatgacgggctgagccgcggagaagcggaggacatgctg
atgagggttccccgggatggggccttcctgatccggaagcgggaaggttctgactcctac
gccatcaccttcagggccaggggcaaggtgaagcactgtcgcatcaaccgggacggccgg
cacttcgtgctgggcacctccgcctacttcgagagcctcgtggagctggtcagctactac
gagaagcacgcactctaccggaagatgaaactgcgctaccccgtgacccccgagctcctg
gagcgctacaatatggaaagagatataaactccctctatgatgtcagcaggatgtatgtg
gatcccagtgaaatcagcccttccatgcctcagagaaccgtgaaagctctgtatgactac
aaagccaagcgaaacgatgagctgagcttctgccgtggcgccctcatccacaatgtctcc
aaggagcctgggggctggtggaaaggagactacggaaccagaatccagcagtacttcccg
tccaattacgttgaagacatttcaacagctgacggggaggacctggaaaagcagattatt
gaagacaatcccttagggtctctttgcagaggaatactggatctcaacacctataatgtt
gtaaaggccccacaggggaagaaccagaagcctttcgtctttatcttggagcccaagaag
cagggtgaccctccggtggagtttgccacagacaaggtggaggagctgtttgagtggttc
cagagcatccgggagatcacctggaagatcgacaccaaggagaacaacatgaagtactgg
gagaagaaccagtccatcgccatcgagctctcggacctggtcgtctactgcaaaccaacc
agcaagaccaaggacaacctagaaaaccccgacttccgagaaatccgctccttcgtggag
acaaaggctgacagcatcgtcagacagaaacccaacgatctcttgaaatacaatcaaaag
ggcctgacccgcgtttaccccaagggacagcgggtggactcctccaactacgaccccttc
cgcctctggctgtgtggctcccagatggtggcactcaatttccagacaccagataagtac
ctgcagatgaatcacgccctgttttccctcaatgggcggactggctacgtcctgcagccc
gagagcatgagggcggagaagtacgaccccatgccgcccgagtcccagaggaagatcctg
atgactctgacggtcaaggttctgggggctcgtcatctccccaaacctggacgaagtatt
gcatgtccctttgtggaggtggaaatatgcggagccgaatatgacaacaacaagttcaaa
acaacagttgtgaatgacaacggcctaagccctgtttgggctccgacacaggagaaggtg
acatttgaaatttatgacccaaacctcgcgtttctacgctttgtggtttacgaggaagat
atgttcagcgatcccaactttctcgcgcatgccactttccccattaaaggaatcaaatca
ggatttagatctgttcctctgaagaacggctacagtgaagacatggagctggcttccctc
ctggttttctgtgagatgcggccagtcctggagagcgaagaggagctttactcctcctgc
cgccagctgcggaggcggcaagaagaactgaacaaccagctctttctgtacgacacacac
cagaacttgcgcagcgccaaccgggatgccctggtcagagagttcaacgtcaacgagaac
cagctgcagctgtaccaggagaagtgcaaccgcaggttaagagagaagagagtcagcaac
agcaagttctactcatag
Delphinapterus leucas (beluga whale): 111184170
Help
Entry
111184170 CDS
T05885
Gene name
PLCG1
Definition
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1
KO
K01116
phosphatidylinositol phospholipase C, gamma-1 [EC:
3.1.4.11
]
Organism
dle
Delphinapterus leucas (beluga whale)
Pathway
dle00562
Inositol phosphate metabolism
dle01100
Metabolic pathways
dle01521
EGFR tyrosine kinase inhibitor resistance
dle04012
ErbB signaling pathway
dle04014
Ras signaling pathway
dle04015
Rap1 signaling pathway
dle04020
Calcium signaling pathway
dle04062
Chemokine signaling pathway
dle04064
NF-kappa B signaling pathway
dle04066
HIF-1 signaling pathway
dle04070
Phosphatidylinositol signaling system
dle04072
Phospholipase D signaling pathway
dle04360
Axon guidance
dle04370
VEGF signaling pathway
dle04613
Neutrophil extracellular trap formation
dle04650
Natural killer cell mediated cytotoxicity
dle04658
Th1 and Th2 cell differentiation
dle04659
Th17 cell differentiation
dle04660
T cell receptor signaling pathway
dle04664
Fc epsilon RI signaling pathway
dle04666
Fc gamma R-mediated phagocytosis
dle04670
Leukocyte transendothelial migration
dle04722
Neurotrophin signaling pathway
dle04750
Inflammatory mediator regulation of TRP channels
dle04919
Thyroid hormone signaling pathway
dle04933
AGE-RAGE signaling pathway in diabetic complications
dle04935
Growth hormone synthesis, secretion and action
dle05012
Parkinson disease
dle05022
Pathways of neurodegeneration - multiple diseases
dle05135
Yersinia infection
dle05167
Kaposi sarcoma-associated herpesvirus infection
dle05170
Human immunodeficiency virus 1 infection
dle05171
Coronavirus disease - COVID-19
dle05200
Pathways in cancer
dle05205
Proteoglycans in cancer
dle05206
MicroRNAs in cancer
dle05214
Glioma
dle05223
Non-small cell lung cancer
dle05225
Hepatocellular carcinoma
dle05231
Choline metabolism in cancer
dle05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
Module
dle_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
dle00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
111184170 (PLCG1)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
111184170 (PLCG1)
04014 Ras signaling pathway
111184170 (PLCG1)
04015 Rap1 signaling pathway
111184170 (PLCG1)
04370 VEGF signaling pathway
111184170 (PLCG1)
04064 NF-kappa B signaling pathway
111184170 (PLCG1)
04066 HIF-1 signaling pathway
111184170 (PLCG1)
04020 Calcium signaling pathway
111184170 (PLCG1)
04070 Phosphatidylinositol signaling system
111184170 (PLCG1)
04072 Phospholipase D signaling pathway
111184170 (PLCG1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
111184170 (PLCG1)
04650 Natural killer cell mediated cytotoxicity
111184170 (PLCG1)
04660 T cell receptor signaling pathway
111184170 (PLCG1)
04658 Th1 and Th2 cell differentiation
111184170 (PLCG1)
04659 Th17 cell differentiation
111184170 (PLCG1)
04664 Fc epsilon RI signaling pathway
111184170 (PLCG1)
04666 Fc gamma R-mediated phagocytosis
111184170 (PLCG1)
04670 Leukocyte transendothelial migration
111184170 (PLCG1)
04062 Chemokine signaling pathway
111184170 (PLCG1)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
111184170 (PLCG1)
04919 Thyroid hormone signaling pathway
111184170 (PLCG1)
09156 Nervous system
04722 Neurotrophin signaling pathway
111184170 (PLCG1)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
111184170 (PLCG1)
09158 Development and regeneration
04360 Axon guidance
111184170 (PLCG1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
111184170 (PLCG1)
05206 MicroRNAs in cancer
111184170 (PLCG1)
05205 Proteoglycans in cancer
111184170 (PLCG1)
05231 Choline metabolism in cancer
111184170 (PLCG1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
111184170 (PLCG1)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
111184170 (PLCG1)
05214 Glioma
111184170 (PLCG1)
05223 Non-small cell lung cancer
111184170 (PLCG1)
09164 Neurodegenerative disease
05012 Parkinson disease
111184170 (PLCG1)
05022 Pathways of neurodegeneration - multiple diseases
111184170 (PLCG1)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
111184170 (PLCG1)
09171 Infectious disease: bacterial
05135 Yersinia infection
111184170 (PLCG1)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
111184170 (PLCG1)
05171 Coronavirus disease - COVID-19
111184170 (PLCG1)
05167 Kaposi sarcoma-associated herpesvirus infection
111184170 (PLCG1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
111184170 (PLCG1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
dle04131
]
111184170 (PLCG1)
Enzymes [BR:
dle01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
111184170 (PLCG1)
Membrane trafficking [BR:
dle04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
111184170 (PLCG1)
Endocytosis
Macropinocytosis
Phospholipase C
111184170 (PLCG1)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
SH3_1
PH
C2
SH3_9
SH3_2
PH_12
GDPD
PH_9
Motif
Other DBs
NCBI-GeneID:
111184170
NCBI-ProteinID:
XP_022448104
UniProt:
A0A2Y9PMG8
LinkDB
All DBs
Position
Unknown
AA seq
1291 aa
AA seq
DB search
MAGAASPCANGCGPGAPSDAEVLHLCRSLEVGTVMTLFYSKKSQRPERKTFQVKLETRQI
TWSRGADKIEGAIDIREIKEIRPGKTSRDFDRYQEDPAFRPDQSHCFVILYGMEFRLKTL
SLQATSEDEVNMWIKGLTWLMEDTLQAATPLQIERWLRKQFYSVDRNREDRISAKDLKNM
LSQVNYRVPNMRFLRERLTDLEQRTSDITYGQFAQLYRSLMYSAQKTMDLPFLEASALRA
GERPELCRVSLPEFQQFLLEYQGELWAVDRLQVQEFMLSFLRDPLREIEEPYFFLDEFVT
FLFSKENSIWNSQLDAVCPDAMNNPLSHYWISSSHNTYLTGDQFSSESSLEAYARCLRMG
CRCIELDCWDGPDGMPVIYHGHTLTTKIKFSDVLHTIKEHAFVASEYPVILSIEDHCSIA
QQRNMAQYFKKVLGDTLLTKPVDIAADGLPSPSQLKRKILIKHKKLAEGSAYEEVPTSVM
YSENDISNSIKNGILYLEDPVNHEWYPHYFVLTSSKIYYSEETSSDQGNEDEEEPKEASG
STELHSNEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFW
RNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQT
NAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQE
GQTVMLGNSEFDSLVDLVSYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNP
GFYVEANPMPTFKCAVKALFDYKAQREDELTFTKSAIIQNVEKQEGGWWRGDYGGKKQLW
FPSNYVEEMVSPAALEPEREHLDENSPLGDLLRGVLDVPACQIAIRPEGKNNRPFVFSIS
MASVAHWSLDVAADSQEELQDWVKKIREVAQTADARLTEGKMMERRKKIALELSELVVYC
RPVPFDEEKIGTERACYRDMSSFPETKAEKYVNKAKGKKFLQYNRLQLSRIYPKGQRLDS
SNYDPLPMWICGSQLVALNFQTPDKPMQMNQALFLAGGHCGYVLQPSIMREEAFDPFDKS
SLRGLEPCAICIEVLGARHLPKNGRGIVCPFVELEVAGAEYDSAKQKTEFVVDNGLNPMW
PAKPFHFQISNPEFAFLRFVVYEEDMFSDQNFLAQATFPVKGLKTGYRAVPLKNNYSEDL
ELASLLVKVDVFPAKQENGDLSPFGGASLRERGCDASGQLFHGRAREGSFEARYQQPFED
FRISQEHLADHFDSRERRAPRRTRVNGDNRL
NT seq
3876 nt
NT seq
+upstream
nt +downstream
nt
atggcgggcgccgcgtccccctgcgccaacggctgcgggcccggcgcgccctcggacgcc
gaggtgctgcacctctgccgcagcctcgaggtgggcaccgttatgactttgttctactcc
aagaagtcgcagcggcccgagcggaagaccttccaggtcaagctggagacgcggcagatc
acgtggagccgtggcgccgacaagatcgagggggccattgacattcgagaaatcaaggag
atccgcccggggaagacctcacgggacttcgatcgctaccaagaggatcctgcttttcga
ccggaccagtcacactgctttgtcatcctgtatggaatggaattccgcctgaagaccctg
agcctgcaagctacgtctgaggacgaagtgaacatgtggatcaagggcctgacttggctg
atggaggatacgttgcaggcagccacacccttgcagattgagaggtggctgcggaagcag
ttctactcagtggaccggaatcgtgaggatcgtatatcagccaaggacctgaagaacatg
ctgtcccaggtcaactaccgggtccccaacatgcgcttcctccgagagcggctgacggac
ctggagcagcgcaccagcgacatcacctacgggcagtttgctcagctgtaccgcagcctt
atgtacagcgcccagaagacgatggacctccccttcctggaagccagtgccctgagggcg
ggggagcggccggagctctgccgggtgtcccttcctgagttccagcagttcctcctcgag
taccagggggagctatgggctgtcgaccggctccaggtgcaggagttcatgctcagcttc
cttcgagaccccttgcgagagatcgaggagccttacttcttcctggatgagttcgtcacc
ttcctgttctccaaggagaacagcatatggaattcgcagctggacgccgtgtgccccgac
gccatgaacaaccccctgtcccactactggatctcctcctcgcacaacacgtacctgacc
ggggaccagttttccagcgagtcctccctggaagcctacgcccgctgcctgcggatgggc
tgccgctgcatcgagttggactgctgggatggtccagacgggatgccagtcatttaccac
ggacacaccctgaccaccaagatcaagttctcagacgtcctgcacaccatcaaggagcac
gcctttgtggcctcagagtacccggtcatcttgtccatcgaggaccattgcagcatcgcc
cagcagaggaacatggcccagtacttcaagaaggtgctcggggacacactcctcaccaag
cccgtggacattgctgctgacgggctcccctcacccagccagctcaagaggaagatcctc
atcaagcacaagaagctggctgagggcagtgcctatgaagaggtgcctacgtccgtgatg
tactctgagaacgacatcagcaactccatcaagaatggcatcctctacctggaggacccc
gtgaatcacgagtggtatccccactacttcgttctgaccagtagcaagatctactactcc
gaggagaccagcagtgaccagggcaacgaggacgaggaggagcccaaggaggccagtggc
agcacagagctgcactccaatgagaagtggtttcacgggaagctcggggcaggacgggat
gggcggcacattgccgagcgcctgctcacagagtactgcatcgagaccggggcccccgac
ggctccttcctcgtgcgcgagagcgagaccttcgtgggcgactacaccctctccttctgg
cggaacggcaaagtccagcactgccggatccactcccggcaggacgcagggacccccaag
ttcttcctgactgacaacctcgtcttcgactcactctatgacctcatcacacactaccag
caggtgcccctgcgctgcaacgaatttgagatgcgcctctcagagcccgtcccgcagacc
aacgcccacgagagcaaagagtggtaccacgcgagcctgaccagagcgcaggccgagcac
atgctgatgcgcgtcccccgggacggggccttcctggtgcggaaacggaatgagcccaac
tcctacgccatctccttccgggctgagggcaagatcaagcactgccgcgtacagcaggag
ggccagaccgtgatgctgggcaactcagagtttgacagcctcgtggacctcgtcagctac
tacgagaagcatcccctgtaccgcaagatgaagctacgctatcccatcaacgaggaggca
ctggagaagatcggcacagcggagcctgactatggggccctgtatgagggccgcaacccc
ggcttctacgtggaggcgaaccccatgccaactttcaagtgcgccgtcaaagctctcttc
gactacaaggcccagagagaggacgagctgactttcaccaagagcgccatcatccagaac
gtggagaagcaggaaggaggctggtggcgtggtgactatggtgggaagaagcagctgtgg
ttcccgtcgaactacgtggaagagatggtcagccctgcggccctggaacctgagagggag
cacttggacgagaacagccccctgggggacttgctgcggggggtcttggatgtgccggct
tgtcagatagccatccgtcctgagggcaagaacaaccggcccttcgtcttctccatcagc
atggcatcggtggcacactggtccctagatgtggctgccgactcacaggaggagctgcag
gactgggtgaaaaagatccgggaagtggcccagaccgcggatgccaggctcactgagggg
aagatgatggagcggaggaagaagatcgccctggagctctccgagcttgtcgtctactgc
cggcctgttcccttcgacgaagagaagatcggcacagaacgcgcctgctaccgggacatg
tcgtccttcccggaaaccaaggctgagaagtacgtgaacaaggccaaaggcaagaagttc
ctccagtacaaccggctgcagctctcccgcatctaccccaagggccagcggctggactcc
tccaattacgaccccttgcccatgtggatctgtggcagtcagctggtagccctcaacttc
caaaccccagacaagcctatgcagatgaaccaggccctcttcctggccggcgggcactgt
ggctacgtgctgcagccgagcatcatgcgcgaggaggccttcgacccctttgacaagagc
agcctccgtgggctggagccgtgcgccatctgcatcgaggtgctgggggcccggcacctg
ccgaagaacggccgaggcatcgtgtgtccgttcgtggagcttgaggtggccggtgctgag
tatgacagcgccaagcagaagaccgagtttgtggtggacaacggactgaaccccatgtgg
ccagccaagcccttccacttccagatcagtaaccccgaattcgccttcctgcgctttgtg
gtgtatgaggaagacatgtttagtgaccagaacttcctggctcaggccaccttcccggtg
aagggcctgaagacaggatacagagctgtgcctttgaagaacaactatagtgaggacctg
gagttggcctccctgctcgtcaaggtcgacgttttccctgccaagcaggagaacggcgac
ctcagtccctttgggggtgcgtccctgcgggagcggggctgcgacgcctcgggccagctg
tttcacggccgggcccgggaaggctccttcgaagctcgctaccagcagccatttgaggac
ttccgcatctcccaggagcatctcgccgaccattttgacagtcgggaacgaagggccccg
cgaaggactcgggtcaatggagacaaccgcctctag
DBGET
integrated database retrieval system